Biomedically useful glycoproteins are the subjects of biomedical investigation because they are implicated in a range of biological functions and could be therapeutic. They’re protein complexes, as in covalently bonded to carbohydrate chain molecules (glycans), involved in immunity, protein stability, and intercellular communication. Here in this blog, I’ll give you a brief summary of what’s happening in glycoprotein science—synthesis, applications, and promise.
Progress in Glycoprotein Synthesis
You can’t even produce exact-structure glycoproteins because the glycosylation machinery is so sophisticated. But we are quite good at generating these molecules, and in recent years we have.
1. Cell-Free Expression Systems
Glycoproteins can be produced without cells, and with cell-free systems, more glycosylation control can be achieved. It’s a way of getting glycoproteins with the same, specialized glycan architectures needed for drugs.
2. Chemoenzymatic Methods
Combining chemistry with enzymatic manipulations has taken glycoprotein modification one step further. This kind of process gives researchers the ability to tailor the glycan structures precisely and therefore to tailor the activity of therapeutic glycoproteins.
3. Glycan Engineering
Ather novel approach is glycocan remodeling, in which old active glycoproteins are rebuilt to be more efficient and less immune-responsive. This is especially useful when it comes to customizing glycoproteins for a particular drug.
All of these developments are helping us get synthetic glycoproteins commercially produced for use in clinical and research applications.
Therapeutic Applications
Indeed, medicinal glycoproteins are now studied extensively for many diseases, from cancer to infection and even genetic issues. Here are some work highlights thus far:
Cancer Therapy
• Glypican-3 (GPC3) as a Target.
Antibodies have focused on a glycoprotein called glypican-3 that’s overexpressed in hepatocellular carcinoma. Monoclonal antibodies and CAR T-cells targeting GPC3 are in preclinical trials.
• Glycosylation Modifications
If therapeutic antibodies could be modified in the glycan structure, they would be more potent, stable, and half-lived in binding to cancer cells.
Improving Protein Therapeutics: It’s also glycosylated that regulates the pharmacokinetics and stability of drugs. The better glycans, eg by increasing sialylation, the longer the half-life of glycoproteins in blood and the fewer times patients have to take them.
Infectious Disease Vaccines: There are vaccines that are made from glycoproteins, too. They can be re-engineered to mimic molecular characteristics of pathogens to better control the immune system and better protect it.
Analytical Techniques for Glycoproteins
Glycoproteins must be described with powerful analytical methods so that they can be of good quality, stable, and therapeutically useful. And several tactics are perfected for exactly this:
1. Glycan Profiling
The glycosylation dynamics can be characterized by high-throughput glycocan analysis. These devices are needed to check and adhere to therapeutic glycoprotein production.
2. Lectin-Based Analysis
Lectin microarrays are a quick and easy way to look for single glycans. We can use these probes to monitor glycosylation during glycoprotein formation.
3. Mass Spectrometry
You can identify glycan structure and linking types molecular-scale, with mass spectrometry analysis of glycoprotein structure.
Challenges and Future Directions
But there’s still much that needs to be done in developing and using therapeutic glycoproteins:
1. Scalability Issues
It is impossible to create glycoproteins on a mass scale and in high quality. It requires bioprocessing and cell line engineering to fix this.
2. Heterogeneity of Glycosylation
It’s difficult to generate identical glycoproteins because of natural variations in glycosylation. We are studying systems for producing storable glycoproteins.
3. Regulatory Hurdles
The glycoprotein is too specialized for the regulatory system to permit. The control and analysis system must be powerful in order to meet the regulation.
Future Trends
The researchers are trying to work out how to better manage and monitor glycosylation through new glycoengineering and computational methods. They all make better glycoproteins with better drugs. This too might be driven by cross-disciplinary groups of biologists, chemists, and engineers.
Conclusion
Healing glycoproteins are going to change the world. Better synthesis and better biology allowed them to expand into the treatment of difficult diseases. Now that those challenges are being solved, glycoproteins could be an even bigger factor in future therapeutics.
Here is a list of some of Creative Biolabs’ services and products.